, along with his hedge fund Glenview Capital Management, has
increased the fund's stake in healthcare provider Health
Management Associates (
) two separate times since the start of December, according to
GuruFocus Real Time Picks
. The share purchases came about two weeks after HMA issued a
statement in regards to a report done by television program
, which claimed that HMA pressured patients into pursuing
unneeded treatments to boost profits.
The segment aired on Dec. 2, presenting more than a year's worth
of research done by
reporters. The show included physician interviews discussing the
inappropriate hospital admissions to the company's emergency
rooms, as well as patients who were supposedly targeted in the
To refute the claims, HMA held a conference call on Nov. 30,
right before the segment aired, making public its admissions data
which, according to an HMA press release, "demonstrated that
admissions rates from the company's emergency rooms were in line
with national norms and consistent over a several year period."
After the show aired, HMA pointed out that
failed to make any mention of HMA's admissions data that proved
its claims erroneous. HMA also noted that the show focused
entirely on "disgruntled former employees of the company and
former contracted physicians [who] are seeking financial gain
through active litigation with Health Management."
When the company's statements were released, its stock jumped.
data by GuruFocus.com
While it traded around $7 around the time of the segment, it rose
to $9 on Dec. 19, the day Glenview purchased almost 8 million
shares of the company, boosting its stake by 31.14 percent. On
the following day, the fund purchased almost 5 million shares,
which grew its stake by 14.82 percent.
Glenview, whose portfolio consists of more than 40 percent
healthcare stocks, is now over 13 percent owner of HMA's
outstanding shares. While it only owned 10 percent of outstanding
shares in the end of September with 26 million shares, it has
sprouted its current holding to 38,589,730 shares.
Year to date, HMA's market value has delivered about $24 percent
in gains. Its third quarter fiscal results stated an increase in
diluted earnings per share from continuing operations by 5.9
percent, an increase in net revenue by 18 percent, an increase in
adjusted EBITDA by 26.9 percent and an increase in admissions by
4 percent - all compared to year-over-year data.
Its 10-Year Financials reveal a healthy revenue growth rate: 32.2
percent in 10 years, 5.6 percent in five years and 11.3 percent
in the past 12 months. Its average annual growth rate is 10.1
With two stars in Business Predictability, GuruFocus ranks HMA 5
in Financial Strength and 7 in Profitability and Growth.
Glenview Capital has only reduced its stake once since acquiring
HMA's stock in the first quarter of 2011. Other Gurus who have
holdings of HMA include Edward Owens, Columbia Wanger and Richard
Snow (HMA: Holding History).
As of the end of September, HMA remained as Glenview's twelfth
To view more of Glenview Capital's latest trades, go to its Stock
Picks. Also see its undervalued stocks, high-yield companies and
top growth stocks.
About GuruFocus Real Time Picks
GuruFocus Real Time Picks alerts you of the stock purchases and
sales that Gurus have made within the last two days. Follow your
favorite Gurus closely with GuruFocus' Premium Membership! If you
are not a Premium Member, we invite you for a 7-Day Free
Trial.About GuruFocus: GuruFocus.com tracks the stocks picks and
portfolio holdings of the world's best investors. This value
investing site offers stock screeners and valuation tools. And
publishes daily articles tracking the latest moves of the world's
best investors. GuruFocus also provides promising stock ideas in
3 monthly newsletters sent to